1,3-dipropylxanthine has been researched along with muramidase in 1 studies
Studies (1,3-dipropylxanthine) | Trials (1,3-dipropylxanthine) | Recent Studies (post-2010) (1,3-dipropylxanthine) | Studies (muramidase) | Trials (muramidase) | Recent Studies (post-2010) (muramidase) |
---|---|---|---|---|---|
26 | 0 | 0 | 23,777 | 207 | 5,249 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ando, M; Furui, H; Hirano, T; Miyamoto, K; Suzuki, K; Takagi, K | 1 |
1 other study(ies) available for 1,3-dipropylxanthine and muramidase
Article | Year |
---|---|
Effect of xanthine derivatives on chemotactic polypeptide-induced superoxide and enzyme release from human polymorphonuclear leucocytes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine Deaminase; Chemotaxis, Leukocyte; Humans; Male; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Purinergic P1 Receptor Antagonists; Superoxides; Xanthines | 1993 |